US Broker Ratings

Abbott Laboratories (ABT) Stock Analysis: Exploring a 37% Upside Potential Amidst Healthcare Innovations

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, is capturing investor attention with its potential upside of 37.02%, as indicated by the current analyst..

UnitedHealth Group (UNH) Stock Analysis: Healthcare Giant with a 5.11% Upside Potential

UnitedHealth Group Incorporated (NYSE: UNH) stands as a titan in the healthcare sector, boasting a market capitalization of $345.38 billion. Operating primarily in the healthcare plans..

AbbVie Inc. (ABBV) Stock Analysis: Evaluating a 16% Upside Potential with Strong Buy Ratings

AbbVie Inc. (NYSE: ABBV), a leading player in the healthcare sector, has remained a prominent force in the drug manufacturing industry since its inception in 2012...

Cytokinetics, Incorporated (CYTK) Stock Analysis: A 36% Potential Upside in Biotechnology

Cytokinetics, Incorporated (NASDAQ: CYTK), a leading name in the biotechnology sector, presents an intriguing opportunity for investors seeking exposure to healthcare innovation. With a market capitalization..

Nuvalent, Inc. (NUVL) Stock Analysis: Evaluating a Potential 41.52% Upside in Biotech Innovation

Nuvalent, Inc. (NASDAQ: NUVL) is capturing the attention of investors with its robust pipeline of innovative cancer therapies and a notable potential upside of 41.52%. The..

Charles River Laboratories Inte (CRL) Stock Analysis: A 30% Upside Potential Amidst Healthcare Sector Dynamics

Charles River Laboratories International, Inc. (NYSE: CRL) stands as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a robust..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 103% Potential Upside with Robust Revenue Growth

Investors with a keen eye on the biotechnology sector should not overlook ADMA Biologics Inc (NASDAQ: ADMA), a company that presents an intriguing investment opportunity in..

Grifols, S.A. (GRFS) Stock Analysis: Unveiling a 36% Upside Potential Amidst a Challenging Healthcare Landscape

Grifols, S.A. (NASDAQ: GRFS), a renowned player in the healthcare sector, particularly in the drug manufacturing industry, is capturing the attention of investors due to its..

Guardant Health, Inc. (GH) Stock Analysis: 48.3% Revenue Growth Fuels Investor Optimism

Guardant Health, Inc. (NASDAQ: GH), a leader in precision oncology, presents a compelling opportunity for investors captivated by the intersection of healthcare and cutting-edge technology. With..

Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking a 130% Potential Upside in the Biotech Sector

Investors seeking opportunities in the dynamic biotechnology sector should pay close attention to Vaxcyte, Inc. (NASDAQ: PCVX). As a clinical-stage vaccine innovation company, Vaxcyte is making..

Masimo Corporation (MASI) Stock Analysis: Navigating Growth in the Healthcare Sector with a Strong Return on Equity

As Masimo Corporation (NASDAQ: MASI) continues to navigate the complex healthcare landscape, investors are keeping a close eye on this medical device giant. With a market..

Alkermes plc (ALKS) Stock Analysis: Unlocking Potential with a 23.47% Upside

Alkermes plc (NASDAQ: ALKS), a biopharmaceutical company headquartered in Dublin, Ireland, has been gaining attention in the healthcare sector, particularly within the specialty and generic drug..

Doximity, Inc. (DOCS) Stock Report: Analyst Ratings Point to a Promising 26% Upside

Doximity, Inc. (NYSE: DOCS), a leader in the Health Information Services industry, is making waves in the healthcare sector with its innovative digital platform tailored for..

Elanco Animal Health (ELAN) Stock Analysis: Exploring Potential 37% Upside with Strong Buy Ratings

Elanco Animal Health Incorporated (NYSE: ELAN) stands as a prominent player in the healthcare sector, specifically within the drug manufacturers’ landscape focused on specialty and generic..

BrightSpring Health Services (BTSG) Stock Report: A Healthcare Giant with a 4.96% Potential Upside

BrightSpring Health Services, Inc. (BTSG) is capturing the attention of investors with its impressive market presence and robust analyst ratings. Headquartered in Louisville, Kentucky, BrightSpring specializes..

Soleno Therapeutics (SLNO) Investor Outlook: Navigating the Hold Ratings with Promising EPS and Cash Flow

Soleno Therapeutics, Inc. (NASDAQ: SLNO), a pioneering biopharmaceutical company, has carved a niche in the biotechnology sector with its focus on developing therapeutics for rare diseases...

Repligen Corporation (RGEN) Stock Analysis: Exploring a 55% Potential Upside for Investors

Repligen Corporation (NASDAQ: RGEN), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, is catching the eye of investors with..

Bausch + Lomb Corporation (BLCO) Stock Analysis: Unpacking a Potential 13% Upside for Investors

Bausch + Lomb Corporation (NYSE: BLCO) stands as a venerable name in the eye health industry, with roots dating back to 1853. As a subsidiary of..

Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis: Exploring a 57% Upside Potential in the Biotech Sector

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) is capturing investor attention in the biotechnology sector with its impressive potential for growth. Known for focusing on rare neuroendocrine diseases,..

Ionis Pharmaceuticals, Inc. (IONS): Investor Outlook Highlights 33.56% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) is garnering attention from investors due to its compelling growth prospects in the biotechnology sector. With a market capitalization of $12.49..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds